fda warning letters compounded semaglutide tirzepatide 2024 2025 The sent a letter to the maker of Ozempic and Wegovy over unreported potential GLP-1 side effects. Here's what to know Beyond the Headlines: FDA Warning

Park SM, Park HR, Lee JH

Rare side effects and warnings While most people tolerate these medications well, there are a few rare but serious side effects to keep an eye on

Aucklandiae radix targeted PKM2 to alleviate ulcerative colitis: Insights from the photocrosslinking target fishing technique

Like other GLP-1 RAs, a common side-effect of Ozempic is the slowing down of stomach emptying

Activation of GLP-1R also promotes beta cell survival, inhibits gastric emptying, regulates food intake and reduces appetite (1, 5), making it a key pharmacological target for various metabolic disorders including type 2 diabetes (T2D) and obesity (6, 7)